124 related articles for article (PubMed ID: 38079537)
1. Optimization of Pharmacokinetic and In Vitro Safety Profile of a Series of Pyridine Diamide Indirect AMPK Activators.
Shaw SJ; Goff DA; Boralsky LA; Singh R; Sweeny DJ; Park G; Sun TQ; Jenkins Y; Markovtsov V; Issakani SD; Payan DG; Hitoshi Y
J Med Chem; 2023 Dec; 66(24):17086-17104. PubMed ID: 38079537
[TBL] [Abstract][Full Text] [Related]
2. Structure activity relationships leading to the identification of the indirect activator of AMPK, R419.
Shaw SJ; Goff DA; Carroll DC; Singh R; Sweeny DJ; Park G; Jenkins Y; Markovtsov V; Sun TQ; Issakani SD; Hitoshi Y; Payan DG
Bioorg Med Chem; 2022 Oct; 71():116951. PubMed ID: 35973281
[TBL] [Abstract][Full Text] [Related]
3. Identification of novel benzimidazole derivatives as highly potent AMPK activators with anti-diabetic profiles.
Tamura Y; Morita I; Hinata Y; Kojima E; Sasaki Y; Wada T; Asano M; Fujioka M; Hayasaki-Kajiwara Y; Iwasaki T; Matsumura K
Bioorg Med Chem Lett; 2023 Jan; 79():129059. PubMed ID: 36402454
[TBL] [Abstract][Full Text] [Related]
4. 2-Arylthiazolidine-4-carboxylic acid amides (ATCAA) target dual pathways in cancer cells: 5'-AMP-activated protein kinase (AMPK)/mTOR and PI3K/Akt/mTOR pathways.
Li CM; Narayanan R; Lu Y; Hurh E; Coss CC; Barrett CM; Miller DD; Dalton JT
Int J Oncol; 2010 Oct; 37(4):1023-30. PubMed ID: 20811725
[TBL] [Abstract][Full Text] [Related]
5. Novel small-molecule AMP-activated protein kinase allosteric activator with beneficial effects in db/db mice.
Zhang LN; Xu L; Zhou HY; Wu LY; Li YY; Pang T; Xia CM; Qiu BY; Gu M; Dong TC; Li JY; Shen JK; Li J
PLoS One; 2013; 8(8):e72092. PubMed ID: 23977216
[TBL] [Abstract][Full Text] [Related]
6. Novel small-molecule AMPK activator orally exerts beneficial effects on diabetic db/db mice.
Li YY; Yu LF; Zhang LN; Qiu BY; Su MB; Wu F; Chen DK; Pang T; Gu M; Zhang W; Ma WP; Jiang HW; Li JY; Nan FJ; Li J
Toxicol Appl Pharmacol; 2013 Dec; 273(2):325-34. PubMed ID: 24055643
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis and biological evaluation of 4,7,12,12a-tetrahydro-5H-thieno[3',2':3,4]pyrido[1,2-b]isoquinolines as novel adenosine 5'-monophosphate-activated protein kinase (AMPK) indirect activators for the treatment of type 2 diabetes.
Zhou S; Duan Y; Wang J; Zhang J; Sun H; Jiang H; Gu Z; Tong J; Li J; Li J; Liu H
Eur J Med Chem; 2017 Nov; 140():448-464. PubMed ID: 28987606
[TBL] [Abstract][Full Text] [Related]
8. Flavonoids extracted from mulberry (Morus alba L.) leaf improve skeletal muscle mitochondrial function by activating AMPK in type 2 diabetes.
Meng Q; Qi X; Fu Y; Chen Q; Cheng P; Yu X; Sun X; Wu J; Li W; Zhang Q; Li Y; Wang A; Bian H
J Ethnopharmacol; 2020 Feb; 248():112326. PubMed ID: 31639486
[TBL] [Abstract][Full Text] [Related]
9. Antidiabetic and antiobesity effects of Ampkinone (6f), a novel small molecule activator of AMP-activated protein kinase.
Oh S; Kim SJ; Hwang JH; Lee HY; Ryu MJ; Park J; Kim SJ; Jo YS; Kim YK; Lee CH; Kweon KR; Shong M; Park SB
J Med Chem; 2010 Oct; 53(20):7405-13. PubMed ID: 20873794
[TBL] [Abstract][Full Text] [Related]
10. [Hypoglycemic effect of electroacupuncture at "Tianshu" (ST 25) combined with metformin on rats with type 2 diabetes mellitus based on AMPK].
Shen XT; Zhang SS; Chen XY; Yu Z; Xu B
Zhongguo Zhen Jiu; 2023 Jan; 43(1):53-9. PubMed ID: 36633240
[TBL] [Abstract][Full Text] [Related]
11. Antidiabetic activity of perylenequinonoid-rich extract from Shiraia bambusicola in KK-Ay mice with spontaneous type 2 diabetes mellitus.
Huang M; Zhao P; Xiong M; Zhou Q; Zheng S; Ma X; Xu C; Yang J; Yang X; Zhang TC
J Ethnopharmacol; 2016 Sep; 191():71-81. PubMed ID: 27286915
[TBL] [Abstract][Full Text] [Related]
12. A spotlight on underlying the mechanism of AMPK in diabetes complications.
Behl T; Gupta A; Sehgal A; Sharma S; Singh S; Sharma N; Diaconu CC; Rahdar A; Hafeez A; Bhatia S; Al-Harrasi A; Bungau S
Inflamm Res; 2021 Sep; 70(9):939-957. PubMed ID: 34319417
[TBL] [Abstract][Full Text] [Related]
13. Insulin-like growth factor-1 inhibits apoptosis of rat gastric smooth muscle cells under high glucose condition via adenosine monophosphate-activated protein kinase (AMPK) pathway.
Zhang XZ; Sun Y; Zhang MH; Jin Z
Folia Histochem Cytobiol; 2022; 60(1):74-88. PubMed ID: 35156189
[TBL] [Abstract][Full Text] [Related]
14. Opposing effects on regulated insulin secretion of acute vs chronic stimulation of AMP-activated protein kinase.
Nguyen-Tu MS; Harris J; Martinez-Sanchez A; Chabosseau P; Hu M; Georgiadou E; Pollard A; Otero P; Lopez-Noriega L; Leclerc I; Sakamoto K; Schmoll D; Smith DM; Carling D; Rutter GA
Diabetologia; 2022 Jun; 65(6):997-1011. PubMed ID: 35294578
[TBL] [Abstract][Full Text] [Related]
15. Indirect AMP-Activated Protein Kinase Activators Prevent Incision-Induced Hyperalgesia and Block Hyperalgesic Priming, Whereas Positive Allosteric Modulators Block Only Priming in Mice.
Inyang KE; Burton MD; Szabo-Pardi T; Wentworth E; McDougal TA; Ramirez ED; Pradhan G; Dussor G; Price TJ
J Pharmacol Exp Ther; 2019 Oct; 371(1):138-150. PubMed ID: 31324647
[TBL] [Abstract][Full Text] [Related]
16. Moderately lipophilic 2-(Het)aryl-6-dithioacetals, 2-phenyl-1,4-benzodioxane-6-dithioacetals and 2-phenylbenzofuran-5-dithioacetals: Synthesis and primary evaluation as potential antidiabetic AMPK-activators.
Lepechkin-Zilbermintz V; Bareket D; Gonnord V; Steffen A; Morice C; Michaut M; Munder A; Korshin EE; Contreras JM; Cerasi E; Sasson S; Gruzman A
Bioorg Med Chem; 2023 May; 87():117303. PubMed ID: 37167713
[TBL] [Abstract][Full Text] [Related]
17. [α-lipoic acid ameliorates liver injury in rats with type 2 diabetes mellitus
Qiu X; Yu L; Tian SY; Chen YJ; Yan HL; Liu KZ
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2022 Sep; 38(5):525-529. PubMed ID: 37088764
[TBL] [Abstract][Full Text] [Related]
18. Development of Novel Alkene Oxindole Derivatives As Orally Efficacious AMP-Activated Protein Kinase Activators.
Yu LF; Li YY; Su MB; Zhang M; Zhang W; Zhang LN; Pang T; Zhang RT; Liu B; Li JY; Li J; Nan FJ
ACS Med Chem Lett; 2013 May; 4(5):475-80. PubMed ID: 24900695
[TBL] [Abstract][Full Text] [Related]
19. Metformin activates a duodenal Ampk-dependent pathway to lower hepatic glucose production in rats.
Duca FA; Côté CD; Rasmussen BA; Zadeh-Tahmasebi M; Rutter GA; Filippi BM; Lam TK
Nat Med; 2015 May; 21(5):506-11. PubMed ID: 25849133
[TBL] [Abstract][Full Text] [Related]
20. Cyclocarya paliurus triterpenoids suppress hepatic gluconeogenesis via AMPK-mediated cAMP/PKA/CREB pathway.
Cao J; Zheng R; Chang X; Zhao Y; Zhang D; Gao M; Yin Z; Jiang C; Zhang J
Phytomedicine; 2022 Jul; 102():154175. PubMed ID: 35609386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
